NCT05781945View on ClinicalTrials.gov

COVID-19 Pneumonia and Gut Inflammation

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

January 31, 2022

Study Completion Date

May 1, 2022

Conditions
Inflammation
Interventions
DIETARY_SUPPLEMENT

probiotics

supplementation with Bifidobacterium lactis LA 304, Lactobacillus salivarius LA 302,andLactobacillus acidophilus LA 201+ standard theraph for sars-cov-2

OTHER

standard therapy

standard therapy for sars-cov-2

Trial Locations (1)

00168

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT05781945 - COVID-19 Pneumonia and Gut Inflammation | Biotech Hunter | Biotech Hunter